Tapiero has led Lilly’s emerging markets business unit since 2009 and brings more than 25 years of international business experience from the innovation-driven pharmaceutical company based in Indianapolis, Ind. Currently, he leads the company’s business strategy in many of the world’s fastest-growing markets, such as China, Russia, Brazil, Mexico, South Korea and Turkey. He is a member of Lilly’s executive committee.
Previously, Tapiero served as president of the intercontinental region for Lilly, which comprised offices in Asia, Australia, African and Middle East countries, Canada, Latin America and Russia. Prior to this role, he served as president and GM for both Lilly France and Lilly Brazil, as well as managing director of Lilly Sweden. He has held several sales and finance positions in Indianapolis, France, Sweden and Switzerland since joining Lilly in 1983.
Alan D. Wilson, chairman, president and CEO of McCormick, said, “We are extremely pleased to have Mr. Tapiero join our board. His broad business experience and extensive global background will bring our board meaningful insight and expertise as we continue the global growth of our business.”
Tapiero was born in Morocco and is a Swiss citizen. He obtained MBA degrees from the Ecole Superieure de Commerce at Clermond Ferrand in France and from the American Graduate School of International Management, Glendale, Ariz.